Objective Chronic patients suffering from mood disorder and depression comorbid to other pathologies or drug treatments receive poor preventive screening, insufficient early diagnosis and follow-up; the insurgence of depression with one more pathological condition amplifies the loss of Quality-Adjusted Life Expectancy expected for both depression and the other condition. Lucy is a cross-platform cloud environment continuously collecting biomarkers belonging to psychic and relational life of the person, like anxiety, depression, pain, disability, relational impairment, using screening tools officially validated by medical practice. An advanced relational system, characterized by very low cost for the patient, elaborates information and translates it into objective and communicable data available to the team of attending physicians, providing continuous, updated patient monitoring, through data-mining and smart on the go doctor interface Fields of science medical and health sciencesclinical medicinepneumologyasthmasocial sciencessociologydemographymortalitymedical and health sciencesclinical medicineendocrinologydiabetesmedical and health sciencesbasic medicinepathologymedical and health sciencesbasic medicineneurologystroke Programme(s) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme H2020-EU.3.1.3. - Treating and managing disease Topic(s) PHC-12-2015-1 - Clinical research for the validation of biomarkers and/or diagnostic medical devices Call for proposal H2020-SMEInst-2014-2015 See other projects for this call Sub call H2020-SMEINST-1-2015 Funding Scheme SME-1 - SME instrument phase 1 Coordinator ACONET SRL Net EU contribution € 50 000,00 Address VIA MISURINA 72 I - INT E/F 00135 ROMA Italy See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Centro (IT) Lazio Roma Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 71 429,00
